Suven Life Sciences Allots 1.85 Cr Shares, Raises ₹248.8 Cr

Suven Life Sciences Ltd announced the allotment of 1,85,70,133 equity shares at ₹134 per share on a preferential basis, converting warrants and raising ₹248.83 crore. This issuance increases the company's paid-up equity share capital. The Board also approved the re-appointment of Dr. Vajja Sambasiva Rao as Non-Executive Independent Director for a second five-year term and the incorporation of a wholly-owned subsidiary in Singapore. The board meeting was held on July 8, 2026.